Molybdenum-containing nitrite reductases: Spectroscopic characterization and redox mechanism. 2017

Jun Wang, and Gizem Keceli, and Rui Cao, and Jiangtao Su, and Zhiyuan Mi
a Department of Pharmacy, Food and Pharmaceutical Engineering College , Hubei University of Technology , Wuhan , Hubei 430068 , China.

OBJECTIVE This review summarizes the spectroscopic results, which will provide useful suggestions for future research. In addition, the fields that urgently need more information are also advised. BACKGROUND Nitrite-NO-cGMP has been considered as an important signaling pathway of NO in human cells. To date, all the four known human molybdenum-containing enzymes, xanthine oxidase, aldehyde oxidase, sulfite oxidase, and mitochondrial amidoxime-reducing component, have been shown to function as nitrite reductases under hypoxia by biochemical, cellular, or animal studies. Various spectroscopic techniques have been applied to investigate the structure and catalytic mechanism of these enzymes for more than 20 years. METHODS We summarize the published data on the applications of UV-vis and EPR spectroscopies, and X-ray crystallography in studying nitrite reductase activity of the four human molybdenum-containing enzymes. RESULTS UV-vis has provided useful information on the redox active centers of these enzymes. The utilization of EPR spectroscopy has been critical in determining the coordination and redox status of the Mo center during catalysis. Despite the lack of substrate-bound crystal structures of these nitrite reductases, valuable structural information has been obtained by X-ray crystallography. CONCLUSIONS To fully understand the catalytic mechanisms of these physiologically/pathologically important nitrite reductases, structural studies on substrate-redox center interaction are needed.

UI MeSH Term Description Entries
D008982 Molybdenum A metallic element with the atomic symbol Mo, atomic number 42, and atomic weight 95.95. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase. Molybdenum-98,Molybdenum 98
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D009572 Nitrite Reductases A group of enzymes that oxidize diverse nitrogenous substances to yield nitrite. (Enzyme Nomenclature, 1992) EC 1. Nitrite Reductase,Reductase, Nitrite,Reductases, Nitrite
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Jun Wang, and Gizem Keceli, and Rui Cao, and Jiangtao Su, and Zhiyuan Mi
July 2002, Journal of inorganic biochemistry,
Jun Wang, and Gizem Keceli, and Rui Cao, and Jiangtao Su, and Zhiyuan Mi
November 2004, Biochemistry,
Jun Wang, and Gizem Keceli, and Rui Cao, and Jiangtao Su, and Zhiyuan Mi
May 2022, Molecules (Basel, Switzerland),
Jun Wang, and Gizem Keceli, and Rui Cao, and Jiangtao Su, and Zhiyuan Mi
December 2022, Journal of inorganic biochemistry,
Jun Wang, and Gizem Keceli, and Rui Cao, and Jiangtao Su, and Zhiyuan Mi
February 1975, Nature,
Jun Wang, and Gizem Keceli, and Rui Cao, and Jiangtao Su, and Zhiyuan Mi
August 1990, Trends in biochemical sciences,
Jun Wang, and Gizem Keceli, and Rui Cao, and Jiangtao Su, and Zhiyuan Mi
May 2020, The journal of physical chemistry. A,
Jun Wang, and Gizem Keceli, and Rui Cao, and Jiangtao Su, and Zhiyuan Mi
January 1997, Annual review of biochemistry,
Jun Wang, and Gizem Keceli, and Rui Cao, and Jiangtao Su, and Zhiyuan Mi
September 1972, Indian journal of biochemistry & biophysics,
Jun Wang, and Gizem Keceli, and Rui Cao, and Jiangtao Su, and Zhiyuan Mi
August 2013, Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry,
Copied contents to your clipboard!